Journal article

High-risk diffuse large B-cell lymphoma: Can we do better than rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone?

A George, CS Tam, JF Seymour

Leukemia and Lymphoma | TAYLOR & FRANCIS LTD | Published : 2013

DOI: 10.3109/10428194.2013.796059

University of Melbourne Researchers

Citation metrics

4Scopus
4Web of Science
4Dimensions

Keywords

Oncology
3211 Oncology and Carcinogenesis
Rare Diseases
Trial
Orphan Drug
Lymphoma
Abt-199
Cancer
Young
Science & Technology
3201 Cardiovascular Medicine and Haematology
Hematology
Chemotherapy Plus Rituximab
Life Sciences & Biomedicine
Lymphatic Research
Open-Label
Chop
32 Biomedical and Clinical Sciences